title: Invited commentary--prescription drug label adverse events: a call for prioritization: comment on "A quantitative analysis of adverse events and 'overwarning' in drug labeling".
authors: Department of Clinical Pharmacy, School of Pharmacy, University of California, San Francisco, 94143-0622, USA.
authors: Christine
authors: C
authors: Cheng
authors: B Joseph
authors: BJ
authors: Guglielmo